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Can SARS-CoV-2 be detected in breastmilk?
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SCHOOL OF PUBLIC HEALTH AND
INFORMATION SCIENCES

INTRODUCTION
• The Summer Research Opportunity Project is directed by
the Office of the Executive Vice President for Research and
Innovation and the Office of the Provost. SROP allows
students to explore a 10-week research experience to
provide insight into graduate level research possibilities.
• I conducted my SROP in the Infectious Diseases Laboratory
(IDLab) under the guidance of Director Dr. Leslie WolfParrish, and working closely with the Research Lab
Manager, Dr. Subathra Marimuthu. The Infectious Diseases
Laboratory is a CLIA-certified, high complexity laboratory
that completes diagnostic testing for local hospitals, clinics,
and private physicians as well as research testing for
clinical and applied research for the University.
• The SARS-CoV-2 virus causes the coronavirus disease
2019 (COVID-19). Since SARS-CoV-2 has been declared a
world pandemic, there has been much needed research
into the spread of the disease. The IDLab started diagnostic
testing for SARS-CoV-2 on March 11th, 2020. In true
interdisciplinary public health practice, the IDLab has
conducted various research projects, working in conjunction
with a myriad of professionals throughout the University’s
departments.
• Research projects worked included the testing of various
samples from COVID-19 positive patients for genetic
markers of SARS-CoV-2. Samples included upper and
lower respiratory specimens; testicular tissue; amniotic fluid;
cerebrospinal fluid; stool; blood; urine; and breast milk. The
following is the research summary for breast milk samples
collected by Dr. Forest Arnold from the UofL Hospital that
we tested using RT-PCR testing methods.
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METHODS (cont’d)
• Ct (Cycle Threshold) values tell us when the virus was
first detected. A lower Ct value means a higher amount of
viral RNA was present in the original sample and was
therefore detectable sooner through the cycling process.
• RT-PCR tests take ~2 hours after sample cartridges are
primed and loaded, so this provides real-time results to
physicians and their patients.
•Qualitative analysis of test results are determined and
reported where appropriate.
• Control samples and internal controls were included to
assure quality of testing procedures.
•Human RNase P is an internal control for ARIES®
cartridges to show that the sample was correctly
processed and there was no inhibition.
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We hypothesize that:
• The SARS-CoV-2 virus could spread from COVID-19
positive parent to infant through breast milk ingestion.
• Breast milk could have SARS-CoV-2 inhibitory properties.
The purpose of testing breast milk for SARS-CoV-2 genetic
markers are to find out if breast milk from COVID-19 positive
patients can be safely given to infants.
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Figure 2. RT-PCR process of converting RNA to DNA
copies Specific N1 and N3 primers are used at the IDLab
in conjunction with CDC guidelines.
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•

SARS-CoV-2 is an encapsulated RNA virus (Figure 1).
Reverse Transcription real-time Polymerase Chain
Reactions (RT-PCR) (Figure 2) coverts the viral RNA to
DNA.
The ARIES® instruments (Figure 3) first extract RNA from
the sample. RNA is converted into complementary DNA by
reverse transcription. The instruments then cycle through
temperature phases that trigger chemical reactions to
create identical copies of the primer specific to
nucleocapsid gene N1 and N3 (Figure 4) and amplify this
sequence using DNA as a template. Each cycle doubles
the amount of viral DNA copies. Instruments complete 45
cycles. Selected fluorescent tagged N1 and N3 probes
identify the amplified N1 and N3 DNA. The Luminex
ARIES® instrument quantifies the amount of light emitted
after processing samples.
• CDC requirements call for N1 or N2 genome targets
because of a higher sensitivity rate.
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• Because COVID-19 is a very recent disease, there is a lot
of research that needs to done for the SARS-CoV-2 virus,
its effects on the human body, and how it is transmitted
from person to person.
• The results for this limited study suggest that SARS-CoV-2
is not passed from parent to infant through ingestion of
breastmilk.
• Whether SARS-CoV-2 can be transmitted through
breastmilk is important to know because it can help guide
physicians and parent decisions on current and future
breastfeeding protocol following the delivery of an infant in
a hospital and when a parent returns homes after recovery.
• Many small studies have been conducted on breastmilk of
COVID-19 positive patients. Small samples sizes have
made conclusive findings difficult to pronounce.
• Only one patient in Germany has tested positive for the
SARS-CoV-2 virus through breastmilk samples. Findings
were stressed to be anecdotal in this study (Rüdiger Groß,
et al., 2020) as it is the only case known so far that shows
viral material being present in breastmilk.
• Antibody testing of breastmilk (Alisa Fox, et al., 2020) has
shown a significant rise in IgA and IgG antibody types,
suggesting breastmilk samples from previously infected, yet
recovered, individuals could pass on protective properties
to infants. It was also suggested that purified breastmilk
antibodies could be used as a COVID-19 therapeutic.
• CDC recommends breastmilk for consumption by infants, in
a case by case situation, for COVID-19 positive patients.
• Difficulties for this study were brought on by:
• Few participants with a low number in the population,
COVID-19 positive post-birth lactating individuals.
• Giant learning curve for the modes of transmission of
the noval virus.
• Regulation changes requiring new and time-consuming
validation procedures.
• Working around other studies being done concurrently.
• The IDLab is in a constant state of starting new research,
finishing projects, and continuing diagnostic testing for
different pathogens. I learned many assays and procedures
throughout the summer.
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Figure 5. Data for SARS-CoV-2 and Breastmilk

Figure 3. Luminex ARIES® instrument
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Figure 4. Target location for N1 and N3 genes on SARS-CoV-2 viral RNA

• Figure 5 shows the data collected in bar graph form.
• 7 breastmilk samples were collected from 6 COVID-19
respiratory positive patients.
• The positive control sample is made up of the virus only
and has no human cells within the sample. No RNase P
was detected within the positive control, as expected.
• The samples from patients 1-4 were tested and were
determined to be negative for the viral RNA.
• This prompted us to ask if breastmilk had inhibitory
properties for SARS-CoV-2 so we spiked patient 4’s
remaining sample with positive control to see if the
virus would be detected.
• The positive spiked sample was confirmed to be
positive through ARIES® testing, thus showing there
were no inhibitory properties masking the viral RNA
from being transcribed and detected in the ARIES®
SARS-CoV-2 assay.
• All 7 samples were negative for SARS-CoV-2 RNA.
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